Comparison of an inflammation-based prognostic score (GPS) with performance status (ECOG) in patients receiving platinum-based chemotherapy for inoperable non-small-cell lung cancer

The value of an inflammation-based prognostic score (GPS) was compared with performance status (ECOG) in patients (n=109) receiving platinum-based chemotherapy for inoperable non-small-cell lung cancer. On multivariate analysis with ECOG, white cell count and the GPS entered as covariates, only the...

Descripción completa

Detalles Bibliográficos
Autores principales: Forrest, L M, McMillan, D C, McArdle, C S, Angerson, W J, Dunlop, D J
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2004
Materias:
Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409737/
https://www.ncbi.nlm.nih.gov/pubmed/15150622
http://dx.doi.org/10.1038/sj.bjc.6601789
_version_ 1782155847798882304
author Forrest, L M
McMillan, D C
McArdle, C S
Angerson, W J
Dunlop, D J
author_facet Forrest, L M
McMillan, D C
McArdle, C S
Angerson, W J
Dunlop, D J
author_sort Forrest, L M
collection PubMed
description The value of an inflammation-based prognostic score (GPS) was compared with performance status (ECOG) in patients (n=109) receiving platinum-based chemotherapy for inoperable non-small-cell lung cancer. On multivariate analysis with ECOG, white cell count and the GPS entered as covariates, only the GPS was a significant independent predictor of survival (HR 1.88, 95% CI 1.25–2.84, P=0.002).
format Text
id pubmed-2409737
institution National Center for Biotechnology Information
language English
publishDate 2004
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-24097372009-09-10 Comparison of an inflammation-based prognostic score (GPS) with performance status (ECOG) in patients receiving platinum-based chemotherapy for inoperable non-small-cell lung cancer Forrest, L M McMillan, D C McArdle, C S Angerson, W J Dunlop, D J Br J Cancer Clinical The value of an inflammation-based prognostic score (GPS) was compared with performance status (ECOG) in patients (n=109) receiving platinum-based chemotherapy for inoperable non-small-cell lung cancer. On multivariate analysis with ECOG, white cell count and the GPS entered as covariates, only the GPS was a significant independent predictor of survival (HR 1.88, 95% CI 1.25–2.84, P=0.002). Nature Publishing Group 2004-05-04 2004-04-13 /pmc/articles/PMC2409737/ /pubmed/15150622 http://dx.doi.org/10.1038/sj.bjc.6601789 Text en Copyright © 2004 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Clinical
Forrest, L M
McMillan, D C
McArdle, C S
Angerson, W J
Dunlop, D J
Comparison of an inflammation-based prognostic score (GPS) with performance status (ECOG) in patients receiving platinum-based chemotherapy for inoperable non-small-cell lung cancer
title Comparison of an inflammation-based prognostic score (GPS) with performance status (ECOG) in patients receiving platinum-based chemotherapy for inoperable non-small-cell lung cancer
title_full Comparison of an inflammation-based prognostic score (GPS) with performance status (ECOG) in patients receiving platinum-based chemotherapy for inoperable non-small-cell lung cancer
title_fullStr Comparison of an inflammation-based prognostic score (GPS) with performance status (ECOG) in patients receiving platinum-based chemotherapy for inoperable non-small-cell lung cancer
title_full_unstemmed Comparison of an inflammation-based prognostic score (GPS) with performance status (ECOG) in patients receiving platinum-based chemotherapy for inoperable non-small-cell lung cancer
title_short Comparison of an inflammation-based prognostic score (GPS) with performance status (ECOG) in patients receiving platinum-based chemotherapy for inoperable non-small-cell lung cancer
title_sort comparison of an inflammation-based prognostic score (gps) with performance status (ecog) in patients receiving platinum-based chemotherapy for inoperable non-small-cell lung cancer
topic Clinical
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409737/
https://www.ncbi.nlm.nih.gov/pubmed/15150622
http://dx.doi.org/10.1038/sj.bjc.6601789
work_keys_str_mv AT forrestlm comparisonofaninflammationbasedprognosticscoregpswithperformancestatusecoginpatientsreceivingplatinumbasedchemotherapyforinoperablenonsmallcelllungcancer
AT mcmillandc comparisonofaninflammationbasedprognosticscoregpswithperformancestatusecoginpatientsreceivingplatinumbasedchemotherapyforinoperablenonsmallcelllungcancer
AT mcardlecs comparisonofaninflammationbasedprognosticscoregpswithperformancestatusecoginpatientsreceivingplatinumbasedchemotherapyforinoperablenonsmallcelllungcancer
AT angersonwj comparisonofaninflammationbasedprognosticscoregpswithperformancestatusecoginpatientsreceivingplatinumbasedchemotherapyforinoperablenonsmallcelllungcancer
AT dunlopdj comparisonofaninflammationbasedprognosticscoregpswithperformancestatusecoginpatientsreceivingplatinumbasedchemotherapyforinoperablenonsmallcelllungcancer

Ejemplares similares